Cargando…

Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey

BACKGROUND: Vaccination efforts to eradicate polio currently focus on children under 5 years of age, among whom most cases of poliomyelitis still occur. However, in the Democratic Republic of the Congo (DRC), an outbreak of wild poliovirus type 1 occurred in 2010–2011 in which 16% of cases occurred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfonso, Vivian H., Voorman, Arie, Hoff, Nicole A., Weldon, William C., Gerber, Sue, Gadoth, Adva, Halbrook, Megan, Goldsmith, Amelia, Mukadi, Patrick, Doshi, Reena H., Ngoie-Mwamba, Guillaume, Fuller, Trevon L., Okitolonda-Wemakoy, Emile, Muyembe-Tamfum, Jean-Jacques, Rimoin, Anne W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728990/ https://www.ncbi.nlm.nih.gov/pubmed/34986786 http://dx.doi.org/10.1186/s12879-021-06951-6

Ejemplares similares

Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo
por: Alfonso, Vivian H., et al.
Publicado: (2019)

Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo
por: Voorman, Arend, et al.
Publicado: (2017)

Measles antibody levels among vaccinated and unvaccinated children 6–59 months of age in the Democratic Republic of the Congo, 2013–2014
por: Ashbaugh, Hayley R., et al.
Publicado: (2020)

Predictors of measles vaccination coverage among children 6–59 months of age in the Democratic Republic of the Congo
por: Ashbaugh, Hayley R., et al.
Publicado: (2018)

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo
por: Bratcher, Anna, et al.
Publicado: (2021)

Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo
por: Bratcher, Anna, et al.
Publicado: (2022)

Association of Previous Measles Infection With Markers of Acute Infectious Disease Among 9- to 59-Month-Old Children in the Democratic Republic of the Congo
por: Ashbaugh, Hayley R, et al.
Publicado: (2018)

Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure
por: Halbrook, Megan, et al.
Publicado: (2021)

Correction: Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure
por: Halbrook, Megan, et al.
Publicado: (2023)

Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots
por: Higgins, Stephen G., et al.
Publicado: (2019)

Risk Factors for Ebola Exposure in Health Care Workers in Boende, Tshuapa Province, Democratic Republic of the Congo
por: Doshi, Reena H, et al.
Publicado: (2020)

Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013–2014
por: Cheng, Alvan, et al.
Publicado: (2022)

Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo
por: Hoff, Nicole A, et al.
Publicado: (2019)

Evolution of a Disease Surveillance System: An Increase in Reporting of Human Monkeypox Disease in the Democratic Republic of the Congo, 2001–2013
por: Hoff, Nicole A., et al.
Publicado: (2017)

660 The effect of immunization on measles incidence in the Democratic Republic of Congo
por: Doshi, Reena, et al.
Publicado: (2014)

Reported History of Measles and Long-term Impact on Tetanus Antibody Detected in Children 9–59 Months of Age and Receiving 3 Doses of Tetanus Vaccine in the Democratic Republic of the Congo
por: Ashbaugh, Hayley R., et al.
Publicado: (2023)

Reported History of Measles and Long-term Impact on Antibody to Tetanus in Children 6–59 Months of Age Receiving DTP in the Democratic Republic of Congo
por: Ashbaugh, Hayley, et al.
Publicado: (2017)

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo
por: Hoff, Nicole A., et al.
Publicado: (2022)

Smallpox and its eradication in the Democratic Republic of Congo: Lessons learned
por: Muyembe-Tamfum, Jean-Jacques, et al.
Publicado: (2011)

Projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo, as of May 27, 2018
por: Kelly, J. Daniel, et al.
Publicado: (2019)

Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019
por: Worden, Lee, et al.
Publicado: (2019)

Neurological, Cognitive, and Psychological Findings Among Survivors of Ebola Virus Disease From the 1995 Ebola Outbreak in Kikwit, Democratic Republic of Congo: A Cross-sectional Study
por: Kelly, J Daniel, et al.
Publicado: (2019)

Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo
por: Hoff, Nicole A., et al.
Publicado: (2021)

Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo
por: Cheng, Alvan, et al.
Publicado: (2021)

Vaccinating against monkeypox in the Democratic Republic of the Congo
por: Petersen, Brett W., et al.
Publicado: (2019)

Corrigendum to “Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo” [Vaccine: X 9 (2021) 100127]
por: Cheng, Alvan, et al.
Publicado: (2022)

The Impact of Different Types of Violence on Ebola Virus Transmission During the 2018–2020 Outbreak in the Democratic Republic of the Congo
por: Kelly, John Daniel, et al.
Publicado: (2020)

Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo
por: Osadebe, Lynda, et al.
Publicado: (2017)

Real-time predictions of the 2018–2019 Ebola virus disease outbreak in the Democratic Republic of the Congo using Hawkes point process models
por: Kelly, J. Daniel, et al.
Publicado: (2019)

Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011
por: Gumede, Nicksy, et al.
Publicado: (2013)

Adherence to face mask use during the COVID-19 pandemic among women seeking antenatal care in Kinshasa, Democratic Republic of Congo: a facility-based cross-sectional study
por: Nkamba, Dalau Mukadi, et al.
Publicado: (2022)

Estimating the impact of violent events on transmission in Ebola virus disease outbreak, Democratic Republic of the Congo, 2018–2019
por: Wannier, S. Rae, et al.
Publicado: (2019)

Evaluation of the influenza sentinel surveillance system in the Democratic Republic of Congo, 2012–2015
por: Babakazo, Pélagie, et al.
Publicado: (2019)

Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo
por: Switzer, William M, et al.
Publicado: (2012)

Comparison of adverse pregnancy and birth outcomes using archival medical records before and during the first wave of the COVID-19 pandemic in Kinshasa, Democratic Republic of Congo: a facility-based, retrospective cohort study
por: Arena, Patrick J., et al.
Publicado: (2023)

Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo
por: Shaffer, Kelly C. L., et al.
Publicado: (2022)

Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo
por: Kugelman, Jeffrey R., et al.
Publicado: (2014)

The national and provincial burden of medically attended influenza‐associated influenza‐like illness and severe acute respiratory illness in the Democratic Republic of Congo, 2013‐2015
por: Babakazo, Pélagie, et al.
Publicado: (2018)

Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection
por: Rimoin, Anne W, et al.
Publicado: (2018)

Seroreactivity against Marburg or related filoviruses in West and Central Africa
por: Steffen, Imke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n6dijrtdvqt6pm5svn0ivcc1su